These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21166680)
1. Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety, with emphasis on patients with sickle cell disease. Pham BN; Peyrard T; Juszczak G; Beolet M; Deram G; Martin-Blanc S; Dubeaux I; Roussel M; Kappler-Gratias S; Gien D; Poupel S; Rouger P; Le Pennec PY Transfusion; 2011 Jun; 51(6):1249-60. PubMed ID: 21166680 [TBL] [Abstract][Full Text] [Related]
2. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors. Gaspardi AC; Sippert EA; De Macedo MD; Pellegrino J; Costa FF; Castilho L Blood Transfus; 2016 Sep; 14(5):449-54. PubMed ID: 27177398 [TBL] [Abstract][Full Text] [Related]
3. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Dezan MR; Ribeiro IH; Oliveira VB; Vieira JB; Gomes FC; Franco LAM; Varuzza L; Ribeiro R; Chinoca KZ; Levi JE; Krieger JE; Pereira AC; Gualandro SFM; Rocha VG; Mendrone-Junior A; Sabino EC; Dinardo CL Blood Cells Mol Dis; 2017 Jun; 65():8-15. PubMed ID: 28388467 [TBL] [Abstract][Full Text] [Related]
4. Systematic RH genotyping and variant identification in French donors of African origin. Kappler-Gratias S; Auxerre C; Dubeaux I; Beolet M; Ripaux M; Le Pennec PY; Pham BN Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s264-72. PubMed ID: 23867180 [TBL] [Abstract][Full Text] [Related]
5. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Reid ME; Halter Hipsky C; Hue-Roye K; Hoppe C Blood Cells Mol Dis; 2014 Apr; 52(4):195-202. PubMed ID: 24309423 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel polymorphism restricted to the (C)ces type 1 haplotype avoids risk of transfusion deadlock in SCD patients. Silvy M; Granier T; Beley S; Chiaroni J; Bailly P Br J Haematol; 2013 Mar; 160(6):863-7. PubMed ID: 23278863 [No Abstract] [Full Text] [Related]
7. High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD. Castilho L; Rios M; Rodrigues A; Pellegrino J; Saad ST; Costa FF Transfus Med; 2005 Feb; 15(1):49-55. PubMed ID: 15713129 [TBL] [Abstract][Full Text] [Related]
8. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340 [TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of RH and its clinical application. Flegel WA Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Vege S; Westhoff CM Immunohematology; 2006; 22(3):143-7. PubMed ID: 17105364 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the Rh antigen RH48 (JAL). Hustinx H; Poole J; Bugert P; Gowland P; Still F; Fontana S; Scharberg EA; Tilley L; Daniels G; Niederhauser C Vox Sang; 2009 Apr; 96(3):234-9. PubMed ID: 19207167 [TBL] [Abstract][Full Text] [Related]
20. [Identification strategy of RHCE gene variants at the National Blood Group Reference Laboratory: impact on transfusion safety]. Ansart-Pirenne H Transfus Clin Biol; 2006; 13(1-2):13-8. PubMed ID: 16563835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]